Vital Signs: Decrease in Incidence of Diabetes-Related End-Stage Renal Disease among American Indians/Alaska Natives - United States, 1996-2013.
Ann Bullock,Nilka Ríos Burrows,Andrew S. Narva,Karen Sheff,Israel Hora,Akaki Lekiachvili,Hannah Cain,David K. Espey +7 more
Reads0
Chats0
TLDR
Despite well-documented health and socioeconomic disparities among AI/AN, ESRD-D incidence rates among this population have decreased substantially since 1996, and these approaches might be a useful model for diabetes management in other health care systems, especially those serving populations at high risk.Citations
More filters
Journal ArticleDOI
Diabetic Kidney Disease: Challenges, Progress, and Possibilities
TL;DR: Widespread innovation is urgently needed to improve health outcomes for patients with diabetic kidney disease, and characterization of new biomarkers, designing clinical trials that evaluate clinically pertinent end points, and development of therapeutic agents targeting kidney-specific disease mechanisms are needed.
Journal ArticleDOI
Global trends in diabetes complications: a review of current evidence
Jessica L. Harding,Meda E. Pavkov,Dianna J. Magliano,Dianna J. Magliano,Jonathan E. Shaw,Edward W. Gregg +5 more
TL;DR: Data from population-based studies on trends in diabetes complications are synthesised, characterising recent and long-term trends and describing regional variation in the excess risk of complications, where possible, with the objectives of identifying and prioritising gaps for future surveillance and study.
Journal ArticleDOI
Prevalence of diabetic retinopathy and diabetic macular edema in a primary care-based teleophthalmology program for American Indians and Alaskan Natives.
TL;DR: Prevalence of DR in this cohort was approximately half that in previous reports for AI/AN, and prevalence of DME was less than that reported in non-AI/AN populations.
Journal ArticleDOI
Premature mortality projections in the USA through 2030: a modelling study.
Ana F. Best,Emily A. Haozous,Amy Berrington de Gonzalez,Pavel Chernyavskiy,Neal D. Freedman,Patricia Hartge,David A. Thomas,Philip S. Rosenberg,Meredith S. Shiels +8 more
TL;DR: This study aims to project premature mortality trends through 2030, and to estimate the total number of projected deaths, the projected number of potential years of life lost due to premature mortality, and the effect of reducing projected accidental death rates by 2% per year.
Journal ArticleDOI
Global trend of diabetes mortality attributed to vascular complications, 2000–2016
TL;DR: Diabetic vascular complication-related deaths had increased substantially during 2000–2016, mainly driven by the increased mortality of renal complications.
References
More filters
Journal ArticleDOI
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
Barry M. Brenner,Mark E. Cooper,Dick de Zeeuw,William F. Keane,William E. Mitch,Hans-Henrik Parving,Giuseppe Remuzzi,Steven M. Snapinn,Zhonxin Zhang,Shahnaz Shahinfar +9 more
TL;DR: Losartan conferred significant renal benefits in patients with type 2 diabetes and nephropathy, and it was generally well tolerated.
Journal ArticleDOI
Permutation tests for joinpoint regression with applications to cancer rates
TL;DR: A joinpoint regression model is applied to describe continuous changes in the recent trend and the grid-search method is used to fit the regression function with unknown joinpoints assuming constant variance and uncorrelated errors.
Journal ArticleDOI
Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial
TL;DR: Routine administration of a fixed combination of perindopril and indapamide to patients with type 2 diabetes was well tolerated and reduced the risks of major vascular events, including death, which suggest that over 5 years, one death due to any cause would be averted.
Journal ArticleDOI
A Framework for Public Health Action: The Health Impact Pyramid
TL;DR: A 5-tier pyramid best describes the impact of different types of public health interventions and provides a framework to improve health and implements interventions at each of the levels to achieve the maximum possible sustained public health benefit.
Related Papers (1)
US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States
Rajiv Saran,Bruce M. Robinson,Kevin C. Abbott,Lawrence Y. Agodoa,Patrick Albertus,John Z. Ayanian,Rajesh Balkrishnan,Jennifer L. Bragg-Gresham,Jie Cao,Joline L.T. Chen,Elizabeth Cope,Sai Dharmarajan,Xue Dietrich,Ashley Eckard,Paul W. Eggers,Charles Gaber,Daniel L. Gillen,Debbie S. Gipson,Haoyu Gu,Susan M. Hailpern,Yoshio N. Hall,Yun Han,Kevin He,Paul C. Hébert,Margaret E. Helmuth,William H. Herman,Michael Heung,David W. Hutton,Steven J. Jacobsen,Nan Ji,Yan Jin,Kamyar Kalantar-Zadeh,Alissa Kapke,Ronit Katz,Csaba P. Kovesdy,Vivian Kurtz,Danielle Lavallee,Yi Li,Yee Lu,Keith McCullough,Miklos Z. Molnar,Maria E. Montez-Rath,Hal Morgenstern,Qiao Mu,Purna Mukhopadhyay,Brahmajee K. Nallamothu,Danh V. Nguyen,Keith C. Norris,Ann M. O’Hare,Yoshitsugu Obi,Jeffrey Pearson,Ronald L. Pisoni,Brett Plattner,Friedrich K. Port,Praveen K. Potukuchi,Panduranga S. Rao,Kaitlyn Ratkowiak,Vanessa A. Ravel,Debabrata Ray,Connie M. Rhee,Douglas E. Schaubel,David T. Selewski,Sally F. Shaw,Jiaxiao Shi,Monica Shieu,John J. Sim,Peter X.-K. Song,Melissa Soohoo,Diane Steffick,Elani Streja,Manjula Kurella Tamura,Francesca Tentori,Anca Tilea,Lan Tong,Megan Turf,Dongyu Wang,Mia Wang,Kenneth J. Woodside,April Wyncott,Xin Xin,Wei Zeng,Lindsay Zepel,Sai Zhang,Hui Zho,Richard A. Hirth,Vahakn Shahinian +85 more